🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to users injecting products of uncertain source.

Some professionals stated the demand for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking fines, prosecution or prison.

Platform Reaction and Material Removal

According to TikTok, the platform has taken down problematic material and banned related keywords and search suggestions. The organization said it was committed to keeping the service secure and investing in enhancing compliance measures.

Digital Trading Operations

Research also found communities with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, filled with images of slimming results, positive testimonials and detailed instructions for preparing or administering at home.

Within minutes of entering one community, a seller posted WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.

Product Information and Pricing

Inside these communities, messages display dark colored parcels with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already encountered individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to possibly significant health risks”.